Yale’s Adam Mecca, MD, PhD Discusses ALX-001 with NeurologyLive

by Tim Siegert | Nov 14, 2023 | News

Allyx sets Phase II plans for AD in motion after Phase Ia

by Tim Siegert | Oct 31, 2023 | News

NIA Small Business Showcase: Allyx Therapeutics, Inc.

by mike | Jun 15, 2022 | News

Bristol Myers drug candidate repairs neuronal damage in Alzheimer’s mouse models

by mike | Jun 15, 2022 | News

Allyx, BMS and Yale Announce License Agreement

by mike | Jan 13, 2021 | News

Drug Restores Cells and Memories in Alzheimer’s Mouse Models

by mike | Jul 5, 2017 | News